跳至主要内容
临床试验/ACTRN12621000413820
ACTRN12621000413820已完成未知

Investigating the efficacy of combining mussel with fucoidan as a supplement on insulin resistance and joint pain outcomes in adults of Chinese ethnicity

niversity of Auckland0 个研究点目标入组 146 人开始时间: 2021年4月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
146

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
30 Years 至 80 Years(—)
性别
All

入选标准

  • Chinese participants with Prediabetes defined by recent HbA1c between 39-49 mmol/mol, and lasting knee or hip joint pain (e.g. hip or knee pain) for the last three months or longer

排除标准

  • Diabetes, Known or suspected seafood (fish and shellfish) allergy, Currently taking a green-lipped mussel supplement, Previous joint replacement surgery, or planning this within the next six months, Pregnant or breastfeeding, or intending to become pregnant within the next six months, Previous bariatric surgery, Conditions which may influence body weight regulation (e.g. malabsorption, thyroid disorders), Taking any glucose-lowering medications, systemic steroids, or blood thinners, Thalassemia, asthma, gout, liver disease, kidney disease, Planning major changes to physical activity within the next six months, Significant weight loss or weight gain within the last six months, Fear of needles or giving blood, and No access to a smartphone, tablet, or Internet.

研究者

发起方
niversity of Auckland

相似试验